In this study, resveratrol treatment increased SIRT1-induced mitophagy in the DEX-treated osteoblasts via PI3K/Akt/mTOR signaling pathway, which suggested that the PI3K/Akt/mTOR signaling pathway might be a target for osteoporosis therapy. Here, AKT1 is linked to osteoporosis.